Entero Therapeutics Inc (ENTO) concluded trading on Thursday at a closing price of $0.41, with 52.18 million shares of worth about $21.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.11% during that period and on May 29, 2025 the price saw a gain of about 4.57%. Currently the company’s common shares owned by public are about 4.77M shares, out of which, 4.67M shares are available for trading.
Stock saw a price change of 4.30% in past 5 days and over the past one month there was a price change of 17.05%. Year-to-date (YTD), ENTO shares are showing a performance of -33.76% which decreased to -83.97% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.19 but also hit the highest price of $2.86 during that period. The average intraday trading volume for Entero Therapeutics Inc shares is 714.43K. The stock is currently trading 3.69% above its 20-day simple moving average (SMA20), while that difference is down -2.67% for SMA50 and it goes to -15.13% lower than SMA200.
Entero Therapeutics Inc (NASDAQ: ENTO) currently have 4.77M outstanding shares and institutions hold larger chunk of about 2.97% of that.
The stock has a current market capitalization of $1.97M and its 3Y-monthly beta is at 0.80. It has posted earnings per share of -$7.32 in the same period. It has Quick Ratio of 2.90 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ENTO, volatility over the week remained 6.24% while standing at 4.72% over the month.
